Literature DB >> 15919949

Role of N-linked glycosylation of the Hendra virus fusion protein.

James Richard Carter1, Cara Theresia Pager, Stephen Derrick Fowler, Rebecca Ellis Dutch.   

Abstract

The Hendra virus fusion (F) protein contains five potential sites for N-linked glycosylation in the ectodomain. Examination of F protein mutants with single asparagine-to-alanine mutations indicated that two sites in the F(2) subunit (N67 and N99) and two sites in the F(1) subunit (N414 and N464) normally undergo N-linked glycosylation. While N-linked modification at N414 is critical for protein folding and transport, F proteins lacking carbohydrates at N67, N99, or N464 remained fusogenically active. As N464 lies within heptad repeat B, these results contrast with those seen for several paramyxovirus F proteins.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15919949      PMCID: PMC1143676          DOI: 10.1128/JVI.79.12.7922-7925.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  17 in total

Review 1.  Virus membrane fusion proteins: biological machines that undergo a metamorphosis.

Authors:  R E Dutch; T S Jardetzky; R A Lamb
Journal:  Biosci Rep       Date:  2000-12       Impact factor: 3.840

2.  Efficient selection for high-expression transfectants with a novel eukaryotic vector.

Authors:  H Niwa; K Yamamura; J Miyazaki
Journal:  Gene       Date:  1991-12-15       Impact factor: 3.688

3.  N-glycans of F protein differentially affect fusion activity of human respiratory syncytial virus.

Authors:  G Zimmer; I Trotz; G Herrler
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

4.  Sequence differences between glycosylated and non-glycosylated Asn-X-Thr/Ser acceptor sites: implications for protein engineering.

Authors:  Y Gavel; G von Heijne
Journal:  Protein Eng       Date:  1990-04

5.  Influence of N-glycans on processing and biological activity of the nipah virus fusion protein.

Authors:  Markus Moll; Andreas Kaufmann; Andrea Maisner
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

6.  Influence of acylation sites of influenza B virus hemagglutinin on fusion pore formation and dilation.

Authors:  Makoto Ujike; Katsuhisa Nakajima; Eri Nobusawa
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

7.  Human immunodeficiency virus type 1 envelope glycoprotein is modified by O-linked oligosaccharides.

Authors:  H B Bernstein; S P Tucker; E Hunter; J S Schutzbach; R W Compans
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

8.  Tunicamycin inhibits the expression of functional thrombin receptors on human T-lymphoblastoid cells.

Authors:  A Tordai; L F Brass; E W Gelfand
Journal:  Biochem Biophys Res Commun       Date:  1995-01-26       Impact factor: 3.575

9.  Subcellular localization and calcium and pH requirements for proteolytic processing of the Hendra virus fusion protein.

Authors:  Cara Theresia Pager; Mark Allen Wurth; Rebecca Ellis Dutch
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

10.  A dual-functional paramyxovirus F protein regulatory switch segment: activation and membrane fusion.

Authors:  Charles J Russell; Karen L Kantor; Theodore S Jardetzky; Robert A Lamb
Journal:  J Cell Biol       Date:  2003-10-27       Impact factor: 10.539

View more
  29 in total

Review 1.  Modes of paramyxovirus fusion: a Henipavirus perspective.

Authors:  Benhur Lee; Zeynep Akyol Ataman
Journal:  Trends Microbiol       Date:  2011-04-20       Impact factor: 17.079

2.  C-terminal tyrosine residues modulate the fusion activity of the Hendra virus fusion protein.

Authors:  Andreea Popa; Cara Teresia Pager; Rebecca Ellis Dutch
Journal:  Biochemistry       Date:  2011-01-20       Impact factor: 3.162

3.  Characterization of human metapneumovirus F protein-promoted membrane fusion: critical roles for proteolytic processing and low pH.

Authors:  Rachel M Schowalter; Stacy E Smith; Rebecca Ellis Dutch
Journal:  J Virol       Date:  2006-09-13       Impact factor: 5.103

4.  Polybasic KKR motif in the cytoplasmic tail of Nipah virus fusion protein modulates membrane fusion by inside-out signaling.

Authors:  Hector C Aguilar; Kenneth A Matreyek; Daniel Y Choi; Claire Marie Filone; Sophia Young; Benhur Lee
Journal:  J Virol       Date:  2007-02-14       Impact factor: 5.103

5.  Trimeric transmembrane domain interactions in paramyxovirus fusion proteins: roles in protein folding, stability, and function.

Authors:  Everett Clinton Smith; Stacy E Smith; James R Carter; Stacy R Webb; Kathleen M Gibson; Lance M Hellman; Michael G Fried; Rebecca Ellis Dutch
Journal:  J Biol Chem       Date:  2013-10-31       Impact factor: 5.157

6.  Hendra virus fusion protein transmembrane domain contributes to pre-fusion protein stability.

Authors:  Stacy Webb; Tamas Nagy; Hunter Moseley; Michael Fried; Rebecca Dutch
Journal:  J Biol Chem       Date:  2017-02-17       Impact factor: 5.157

7.  Cathepsin L is involved in proteolytic processing of the Hendra virus fusion protein.

Authors:  Cara Theresia Pager; Rebecca Ellis Dutch
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

8.  Endocytosis plays a critical role in proteolytic processing of the Hendra virus fusion protein.

Authors:  Kelly Ann Meulendyke; Mark Allen Wurth; Richard O McCann; Rebecca Ellis Dutch
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

9.  N-glycans on Nipah virus fusion protein protect against neutralization but reduce membrane fusion and viral entry.

Authors:  Hector C Aguilar; Kenneth A Matreyek; Claire Marie Filone; Sara T Hashimi; Ernest L Levroney; Oscar A Negrete; Andrea Bertolotti-Ciarlet; Daniel Y Choi; Ian McHardy; Jennifer A Fulcher; Stephen V Su; Mike C Wolf; Luciana Kohatsu; Linda G Baum; Benhur Lee
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

Review 10.  Emerging paramyxoviruses: molecular mechanisms and antiviral strategies.

Authors:  Hector C Aguilar; Benhur Lee
Journal:  Expert Rev Mol Med       Date:  2011-02-24       Impact factor: 5.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.